KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Deferred Taxes (2016 - 2025)

Bausch Health Companies' Deferred Taxes history spans 17 years, with the latest figure at $155.0 million for Q4 2025.

  • For Q4 2025, Deferred Taxes fell 8.82% year-over-year to $155.0 million; the TTM value through Dec 2025 reached $80.0 million, up 21.21%, while the annual FY2025 figure was $80.0 million, 21.21% up from the prior year.
  • Deferred Taxes for Q4 2025 was $155.0 million at Bausch Health Companies, up from -$24.0 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $170.0 million in Q4 2024 and bottomed at -$106.0 million in Q2 2021.
  • The 5-year median for Deferred Taxes is -$17.0 million (2021), against an average of -$10.7 million.
  • The largest annual shift saw Deferred Taxes skyrocketed 342.11% in 2023 before it crashed 700.0% in 2025.
  • A 5-year view of Deferred Taxes shows it stood at -$88.0 million in 2021, then skyrocketed by 121.59% to $19.0 million in 2022, then skyrocketed by 342.11% to $84.0 million in 2023, then skyrocketed by 102.38% to $170.0 million in 2024, then decreased by 8.82% to $155.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Deferred Taxes are $155.0 million (Q4 2025), -$24.0 million (Q3 2025), and -$42.0 million (Q2 2025).